Nutrition education may help prevent breast cancer recurrence

Providing nutrition education to patients with breast cancer could be beneficial for patients and may help to prevent recurrence of their cancer, according to new research.

Mind body techniques added to aerobic exercise improve rehabilitation outcomes in breast cancer survivors

Mind body techniques added to aerobic exercise improve rehabilitation outcomes in breast cancer survivors

Researchers sought to determine the impact of aerobic exercise training and yoga on survivorship measures in breast cancer survivors.

Eribulin effective for earlier treatment of metastatic breast cancer

Eribulin effective for earlier treatment of metastatic breast cancer

Eribulin is active and well tolerated as first-, second-, or third-line therapy in patients with metastatic breast cancer.

Insulin resistance increases breast cancer risk

Insulin resistance increases breast cancer risk

Study of postmenopausal women suggests hormone levels matter more than excess weight, with regard to predicting breast cancer risk.

Combination therapy can reduce chance of recurrence from small HER2+ breast tumors

Women with stage 1 HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were unlikely to suffer cancer recurrence within 3 years of treatment.

Researchers map paths to cancer drug resistance

The researchers have mapped the steps used by cells of melanoma, breast cancer, and the blood cancer myelofibrosis to become resistant to drugs, allowing for better success in blocking these pathways and further enabling therapies.

Aerobic exercise reduces fatigue women undergoing radiotherapy for breast cancer

Aerobic exercise reduces fatigue women undergoing radiotherapy for breast cancer

Findings in a quasi-experimental study of Taiwanese women with early-stage breast cancer showed the potential for exercise to reduce fatigue in women undergoing radiotherapy.

Mindfulness-based intervention is helpful to younger breast cancer survivors

Mindfulness-based intervention is helpful to younger breast cancer survivors

Younger women with early stage breast cancer who had completed cancer treatment to a 6-week Mindful Awareness Practices (MAPS).

In breast cancer, febrile neutropenia-related admissions account for significant mortality

In breast cancer, febrile neutropenia-related admissions account for significant mortality

Febrile neutropenia-related hospitalizations still account for morbidity, and mortality among patients with breast cancer.

Breast cancer prognosis impacted by race and ethnicity

Breast cancer prognosis impacted by race and ethnicity

The odds of being early breast cancer development and survival chances vary greatly depending on race and ethnicity, according to a new study.

Women with atypical hyperplasia are at higher risk of breast cancer

A new study has better established the future risk of developing breast cancer for those with atypical hyperplasia of the breast.

Breast cancer data analyzed by race/ethnic groups to identify differences in diagnosis, prognosis

Breast cancer data analyzed by race/ethnic groups to identify differences in diagnosis, prognosis

Race and ethnicity may play a role in the timing of breast cancer diagnosis and the prognosis of the woman's disease.

Risk for leukemia after treatment for early stage breast cancer higher than reported

According to results of a new, retrospective study, the risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer is double that previously reported.

Autologous breast reconstruction yields higher satisfaction rates

Research indicates that women who undergone mastectomy have greater satisfaction when breast reconstruction is performed using the patient's own tissues, rather than implants.

Trastuzumab improves long-term survival of HER2-positive breast cancer patients

Trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients, according to a large national study.

Autologous breast reconstruction shows higher satisfaction rate

Autologous breast reconstruction shows higher satisfaction rate

For women undergoing breast reconstruction, autologous reconstruction leads to higher satisfaction than alloplastic reconstruction, but secondary correction is often required.

Targeting microRNA may benefit some patients with ovarian and breast cancer

Researchers believe they may have found a molecule-based approach to halting the destructive quality of the 3q26.2 amplicon, a frequent chromosomal aberrations seen in many cancers, including ovarian and breast cancers.

Older patients with breast cancer still undergo radiation despite its limited benefit

Women over 70 years with early stage breast cancer are very likely to receive radiation therapy, despite evidence of that it might not be the best form of treatment.

Intra-operative technology improves lumpectomy procedures for many breast cancer patients

Intra-operative technology improves lumpectomy procedures for many breast cancer patients

New intra-operative technology aids lumpectomy procedures by detecting microscopic amounts of cancer cells on tumor tissue.

Cancer risks associated with atypical hyperplasia of the breast discussed

Cancer risks associated with atypical hyperplasia of the breast discussed

Considerations for women with atypical hyperplasia include screening and chemoprevention, and more patient education is often needed.

Communication gaps between patients with breast cancer, caregivers, oncology care team

Communication gaps between patients with breast cancer, caregivers, oncology care team

Discussions on basic disease information between patients with metastatic breast cancer, caregivers, and oncologists.

Supplemental breast cancer screening with ultrasound may increase costs more than overall health in women with dense breasts

Supplemental ultrasound screening for all US women with dense breasts would substantially increase health care costs with little improvement in overall health.

Widely used osteoporosis drug may prevent breast, lung, and colon cancers

The most commonly used medications for osteoporosis worldwide, bisphosphonates, may also prevent certain kinds of lung, breast, and colon cancers, according to two recent studies.

Risk-based screening misses breast cancers in women in their 40s

A study of breast cancers detected with screening mammography found that strong family history and dense breast tissue were commonly absent in women ages 40 to 49 years at diagnosis of breast cancer.

Breast cancer outcomes in young women improving, but still better in white than in blacks

Breast cancer outcomes in young women improving, but still better in white than in blacks

Researchers conducted a study to determine whether there is a differential effect of race on outcomes for women with breast cancer.

Many breast cancer patients do not receive shorter radiation treatment

Although the use of a radiation treatment that is shorter in duration and less costly has increased among women with early stage breast cancer who underwent breast conserving surgery, most patients who meet guidelines to receive this treatment do not.

Genetic analyses identify more mutations and help plan treatment for breast cancer

Genetic analyses identify more mutations and help plan treatment for breast cancer

Three studies presented at the 2014 San Antonio Breast Cancer Symposium (SABCS): Cancer risk test detected 105% more mutations in cancer-causing genes than conventional BRCA testing alone; researchers at leading cancer research institutions validate use of companion diagnostic test to detect a DNA scar in tumor that is indicative of a dysfunctional DNA repair pathway; UK researchers evaluated the use of companion diagnostic assays to identify which patients would respond to carboplatin or docetaxel.

Updated results shows SC trastuzumab as safe and effective as IV formulation

Updated results shows SC trastuzumab as safe and effective as IV formulation

Researchers have found that subcutaneous trastuzumab has a similar safety profile and similar event-free survival rate with intravenous trastuzumab.

New breast cancer classification based on epigenetics

Two subgroups of breast tumors have been identified, based on epigenetic alterations.

Breast cancer treatment-related leukemia risk higher than thought

Breast cancer treatment-related leukemia risk higher than thought

Among early-stage breast cancer patients who undergo chemotherapy and/or radiation treatment, the risk for developing treatment-related leukemia, though low, is still double what experts had previously thought.

New device may ease mammography discomfort

Researchers have developed a new device that may help make mammography more comfortable for women.

3-D mammography improves cancer detection in dense breasts

Digital breast tomosynthesis has the potential to significantly increase the cancer detection rate of mammography screening in women that have dense breasts.

Mobile support system keeps up with a younger generation of breast cancer survivors

Mobile support system keeps up with a younger generation of breast cancer survivors

A new digital program using a Web site and social media aims to meet the unique support needs of women younger than 40 years with breast cancer.

Impact of adding bevacizumab to presurgery chemotherapy for triple-negative breast cancer varies

The addition of bevacizumab to standard presurgery chemotherapy showed greater benefit in those whose cancers were classified as basal-like by gene expression assay, compared with those whose cancers were nonbasal-like.

Fulvestrant improves survival over anastrozole for patients with advanced breast cancer

Fulvestrant did more to improve survival than anastrozole for patients with advanced, hormone receptor-positive breast cancer, according to data.

Breast cancer vaccine shows promise in small clinical trial

A breast cancer vaccine is safe in patients with metastatic breast cancer, as indicated by the results of an early clinical trial.

Breast cancer has different biological characteristics and outcomes in men and women

Results from the largest series of male breast cancer cases ever studied shows improvement in male survival, but not equal to that seen in women with breast cancer.

Better tests and treatments for breast cancer may come from new insights into its spread

A study examining tumor cells from patients with breast cancer has provided compelling evidence so far that a specific trio of cells is required for the spread of breast cancer.

No higher risk of breast cancer seen for women with migraines

No higher risk of breast cancer seen for women with migraines

Since both conditions involve hormone levels, researchers suspected a possible connection.

Adding ultrasound to routine mammography improves cancer detection in dense breasts

Among women with denser breasts, an additional ultrasound can detect breast cancers not discovered by mammogram.

Nab-paclitaxel demonstrated superior activity vs paclitaxel in early breast cancer

Nab-paclitaxel demonstrated superior activity vs paclitaxel in early breast cancer

Nab-paclitaxel has demonstrated significant benefit for patients with early high-risk breast cancer when compared with conventional solvent-based paclitaxel, according to recent research.

Multigene test can predict risk of recurrence for women with ductal carcinoma in situ

A multigene test was validated as a predictor of risk of disease recurrence among women treated with breast-conserving surgery alone for ductal carcinoma in situ (DCIS), according to data from a large study.

Mental health inequalities in detecting breast cancer

Women with a mental illness are less likely to be screened for breast cancer, according to new research.

Lowering dietary fat intake reduces death rates in some women with breast cancer

Reducing dietary fat intake reduced death rates significantly in those with hormone-unrelated breast cancer, according to recent data.

SABCS: Novel breast cancer drugs show promise in early trials

SABCS: Novel breast cancer drugs show promise in early trials

Pictilisib and pembrolizumab may prolong survival for women with advanced breast cancer, according to data from preliminary studies.

Adding ovarian suppression to tamoxifen reduced recurrence for some premenopausal breast cancer

Among premenopausal women with early stage, HR-positive breast cancer, the addition of ovarian suppression to tamoxifen reduced breast cancer recurrence.

Tamoxifen found to lower breast cancer rates among high-risk women in trial

The International Breast Cancer Intervention Study-I (IBIS-I) trial found that tamoxifen significantly decreased the incidence of all breast cancers, according to data presented at the 2014 San Antonio Breast Cancer Symposium.

SABCS: Male breast cancer prognosis falls behind that for women

SABCS: Male breast cancer prognosis falls behind that for women

Although survival in male breast cancer has improved, treatment lags behind when compared to the cancer therapy women receive.

Pembrolizumab safe, and even effective in some patients, for triple-negative breast cancer

Pembrolizumab was well tolerated and yielded durable responses in patients with metastatic triple-negative breast cancer, according to recent trial data.

Capecitabine does not improve survival in elderly patients with early stage breast cancer

In elderly patients with moderate- to high-risk early stage breast cancer for whom standard chemotherapy is too toxic, capecitabine did not improve outcomes when tested as monotherapy, according to recent data.

Resistance exercise improves fatigue in patients with breast cancer receiving chemotherapy

Resistance exercise improves fatigue in patients with breast cancer receiving chemotherapy

Per a new study, resistant exercise decreased physical fatigue and maintained quality of life among patients with breast cancer receiving adjuvant chemotherapy.

Trastuzumab improves survival for HER2-positive breast cancer

Trastuzumab improves survival for HER2-positive breast cancer

Trastuzumab improved overall survival in early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer.

Vaccine targeting breast cancers produced robust immune response

A DNA vaccine targeting the breast cancer-associated antigen mammaglobin-A was proven safe and found to effectively elicit immune responses in women with metastatic breast cancer, according to a new study.

Patients with BRCA 1/2 mutations not at increased risk for anthracycline-induced cardiotoxicity

Patients with BRCA 1/2 mutations not at increased risk for anthracycline-induced cardiotoxicity

Breast cancer patients with BRCA 1/2 gene mutations do not have an increased risk of anthracycline-induced cardiac toxicity.

No association between migraine and breast cancer risk

No association between migraine and breast cancer risk

There is no associated between migraines and risk of breast cancer.

Dietary interventions can improve clinical outcomes for some women with breast cancer

Dietary interventions can improve clinical outcomes for some women with breast cancer

Reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.

National trends in mastectomy for early stage breast cancer examined

An increasing number of of women eligible for breast conservation surgery (BCS) are opting instead for mastectomy, breast reconstruction, and bilateral mastectomy.

Many breast cancer patients overtreated with radiation therapy

Many breast cancer patients overtreated with radiation therapy

Two-thirds of breast-conserving surgical patients undergo six to seven weeks of radiation, but three weeks of higher-dose radiation could be more beneficial.

Inherited mutations typical in triple-negative breast cancer

Inherited mutations typical in triple-negative breast cancer

Deleterious mutations were identified in 14.6 percent of patients in a cohort unselected for family history.

Researchers suggest new follow-up model for breast cancer patients

The surveillance and follow-up of breast cancer survivors has the potential to improve, from the perspective of both patients and the health system.

Study confirms recommendations for genetic screening in patients with triple-negative breast cancer

Study confirms recommendations for genetic screening in patients with triple-negative breast cancer

A recent study recommends that patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2.

Smoking cessation prior to first child decreases risk of breast cancer

Smoking cessation prior to first child decreases risk of breast cancer

Many breast cancer cases in mothers can be averted if women do not smoke cigarettes prior to the birth of their first child.

Breast cancer vaccine shows promise in early testing

Breast cancer vaccine shows promise in early testing

An experimental breast cancer vaccine boosts immune response and appears to slow spread in those with advanced disease.

Counseling over the phone provides access to genetic testing for women in rural areas

Telephone counseling after genetic testing was found just as effective as in-person counseling in many respects, according to new study.

Bisphosphonates may reduce risk of certain breast, colon, and lung cancers

Bisphosphonates may reduce risk of certain breast, colon, and lung cancers

Bisposphonates may also prevent certain types of breast, colon, and lung cancers.

Combining genetic information with risk factors could improve breast cancer prediction

Combining genetic data with information on other risk factors could significantly improve the ability to identify women at highest risk of developing breast cancer, according to a new study.

Current breast cancer treatments measure better than past therapies

Current breast cancer treatments measure better than past therapies

Significant improvements in breast cancer outcomes found despite similar patterns of relapse, research shows.

Can consensus guidelines defining adequate margins decrease unnecessary breast cancer surgeries?

Nearly one quarter of all women who underwent initial breast conservation surgery (BCS) for breast cancer had a subsequent surgical intervention.

Exercise therapy benefits breast cancer survivors

Exercise offers several benefits for breast cancer survivors, including reduced symptoms of lymphedema, according to a new study.

BRCA-related tumors respond to olaparib

Olaparib, an experimental oral cancer drug, has shown an overall tumor response rate of 26% in advanced cancers associated with BRCA1 and BRCA2 mutations, according to recent research.

Prosocial Internet support group not proving beneficial for breast cancer survivors

Prosocial Internet support group not proving beneficial for breast cancer survivors

Participants in prosocial versus standard group have higher level of depression, anxiety after intervention.

Mastectomy numbers on the rise in women eligible for lumpectomy

Mastectomy numbers on the rise in women eligible for lumpectomy

Better breast reconstruction outcomes may be one reason behind the trend of increasing mastectomy rates for early-stage breast cancer patients eligible for lumpectomy.

Helper therapy principle may not be helpful for breast cancer

Helper therapy principle may not be helpful for breast cancer

Distressed survivors or breast cancer may not benefit from helping others, as the helper therapy principle would suggest.

Inadequately management of hot flushes leave women vulnerable

More than 70% of women who have had breast cancer experience menopausal problems, hot flushes in particular, and some cancer survivors consider giving up their post cancer medication to mitigate these conditions.

Complementary, alternative medicine may have higher risk for excessive bleeding during breast cancer surgery

Complementary, alternative medicine may have higher risk for excessive bleeding during breast cancer surgery

Breast cancer patients using herbal supplements had increased risk for adverse bleeding-related outcomes.

More patients opt for mastectomy despite limited, early-stage breast cancer

More patients opt for mastectomy despite limited, early-stage breast cancer

More women with breast cancer are opting for mastectomy rather than undergoing breast conservation surgery.

Calcium channel blockers not found to increase risk of breast cancer

Calcium channel blockers not found to increase risk of breast cancer

Women who take calcium channel blockers to treat their hypertension are not at increased risk for developing breast cancer.

Proton therapy less costly than some alternative radiotherapy techniques

Partial breast irradiation (APBI) with proton therapy, as opposed to whole breast irradiation (WBI), may prove more affordable and have a more beneficial length of treatment for patients with early stage breast cancer.

Preventative therapies for healthy women at high risk of breast cancer

Preventative therapies for healthy women at high risk of breast cancer

SERMs and aromatase inhibitors have been proven to be excellent agents in the preventive setting for ER-positive breast cancer, but newer agents must be found specifically for ER-negative breast cancers, which mostly occur in premenopausal women.

Telephone Support Intervention Beneficial for BRCA Carriers

Telephone Support Intervention Beneficial for BRCA Carriers

Reduction in distress, unmet information needs with telephone-based, peer-support program

Cellular evidence for mind-body connection in breast cancer survivors

Researchers have demonstrated that employing mindfulness meditation or being a member of a support group has a positive physical impact at the cellular level in breast cancer survivors.

New software determines aggressiveness of breast cancer

New software determines aggressiveness of breast cancer

Newly developed software enables genetic mutation analysis of breast cancer tumors, allowing for greater accuracy.

Adding tomosynthesis to mammography is cost effective for dense breasts

The addition of tomosynthesis to biennial digital mammography screening for women with dense breasts should improve breast cancer detection at a reasonable cost.

Treatment options for HER2-positive breast cancer

Treatment options for HER2-positive breast cancer

What are the treatment options for recurrent metastatic HER2-positive breast cancer after trastuzumab therapy?

The Society for Integrative Oncology (SIO) and co-researchers issue a report card on complementary therapies for breast cancer

The Society for Integrative Oncology (SIO) and co-researchers issue a report card on complementary therapies for breast cancer

A majority of breast cancer patients in the U.S. use complementary therapies after a breast cancer diagnosis, but there has been little science-based guidance about their safety and effectiveness.

Mexican women with family history more likely to have triple-negative breast cancer vs. other types

Mexican women with family history more likely to have triple-negative breast cancer vs. other types

Patients of Mexican descent with breast cancer and family history of breast or ovarian cancer were nearly two times as likely to have triple negative breast cancer.

Breast cancer tumor response to neoadjuvant chemotherapy (NAC) measured

Diffuse optical spectroscopic tomographic imaging (DOST) may be useful in predicting which patients will best respond to chemotherapy used to reduce breast cancer tumors before surgery, according to a new study.

Latina patients with breast cancer given more information more likely to enter clinical trials

Latina patients with breast cancer given more information more likely to enter clinical trials

Latina patients with breast cancer had much more awareness of clinical trials versus women who received the typical information.

People with lactose intolerance may have decreased risk of breast, lung, and ovarian cancers

People with lactose intolerance may have decreased risk of breast, lung, and ovarian cancers

People who are lactose intolerant have a decreased risk for developing breast, lung, and ovarian cancers.

Trastuzumab shows benefit years after treatment for HER2+ breast cancer

The addition of trastuzumab to chemotherapy significantly improved the overall and disease-free survival of women with early stage HER2-positive breast cancer.

For breast cancer survivors, tai chi decreases inflammation

For breast cancer survivors, tai chi decreases inflammation

Tai chi may reduce the risk of breast cancer recurrence by decreasing inflammation in patients who have had breast cancer.

Patients with breast cancer at long-term increased risk of first depression

Patients with breast cancer at long-term increased risk of first depression

Women with breast cancer are at an increased long-term risk for developing first depression.

Survival comparable after radiation therapy for tumors in left or right breast

Location of a breast cancer tumor, on the left or right side, does not impact overall survival in patients treated with breast-conserving surgery and adjuvant external beam radiation therapy.

Why early stage breast cancer survivors opt for mastectomy

Cancer stage may play a role in the decision to undergo mastectomy rather than lumpectomy for women with early stage breast cancer, according to recent research.

Exercise therapy, acupuncture improve strength and decrease pain in breast cancer survivors

Exercise therapy, acupuncture improve strength and decrease pain in breast cancer survivors

Researchers identified the benefits of exercise therapy and electro-acupuncture in breast cancer survivors.

Link between obesity and breast cancer confirmed for blacks and Hispanics

Link between obesity and breast cancer confirmed for blacks and Hispanics

For black women and Hispanic women, obesity increases postmenopausal risk of estrogen receptor (ER)-negative and progesterone receptor-positive breast cancer.

For breast cancer survivors, meditation may cause beneficial cellular changes

For breast cancer survivors, meditation may cause beneficial cellular changes

Mindfulness mediation has effects on the cellular level of the body of breast cancer survivors.

Cancer prehabilitation: One step toward improved outcomes

Cancer prehabilitation: One step toward improved outcomes

As cancer care evolves toward anticipatory rather than reactionary care, oncology nurses should consider developing important new skills.

Hot flashes may not be managed adequately in patients treated for breast cancer

Hot flashes may not be managed adequately in patients treated for breast cancer

Hot flashes experienced by women who have been treated for breast cancer are not being sufficiently addressed by clinicians.

Subsidies help breast cancer patients adhere to hormone therapy

A federal prescription-subsidy program for low-income Medicare recipients has increased adherence to hormone therapy to prevent breast cancer recurrence after surgery, according to recent data.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs